Evidence map›Paper›PMID 34992214›Full record

ArticleCommunications biology2022

Inferring the stabilization effects of SARS-CoV-2 variants on the binding with ACE2 receptor.

Mattia Miotto, Lorenzo Di Rienzo, Giorgio Gosti, Leonardo Bo', Giacomo Parisi, Roberta Piacentini, Alberto Boffi, Giancarlo Ruocco, Edoardo Milanetti

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Missense mutations on SynGAP C2 domain impair membrane diffusion.Protein science : a publication of the Protein Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mattia MiottoCenter for Life Nano & Neuroscience, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy.ORCID http://orcid.org/0000-0002-0043-8921
Lorenzo Di RienzoCenter for Life Nano & Neuroscience, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy.
Giorgio GostiCenter for Life Nano & Neuroscience, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy.ORCID http://orcid.org/0000-0002-8571-1404
Leonardo Bo'Center for Life Nano & Neuroscience, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy.
Giacomo ParisiCenter for Life Nano & Neuroscience, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy.
Roberta PiacentiniCenter for Life Nano & Neuroscience, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy.ORCID http://orcid.org/0000-0003-1381-9560
Alberto BoffiCenter for Life Nano & Neuroscience, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy.ORCID http://orcid.org/0000-0003-0896-7892
Giancarlo RuoccoCenter for Life Nano & Neuroscience, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy.ORCID http://orcid.org/0000-0002-2762-9533
Edoardo MilanettiCenter for Life Nano & Neuroscience, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy. edoardo.milanetti@uniroma1.it.ORCID http://orcid.org/0000-0002-3046-5170
Italian Institute of Technology · IT

Funding

European Research Council
6 · The paper itself

Abstract

As the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic continues to spread, several variants of the virus, with mutations distributed all over the viral genome, are emerging. While most of the variants present mutations having little to no effects at the phenotypic level, some of these variants are spreading at a rate that suggests they may present a selective advantage. In particular, these rapidly spreading variants present specific mutations on the spike protein. These observations call for an urgent need to characterize the effects of these variants' mutations on phenotype features like contagiousness and antigenicity. With this aim, we performed molecular dynamics simulations on a selected set of possible spike variants in order to assess the stabilizing effect of particular amino acid substitutions on the molecular complex. We specifically focused on the mutations that are both characteristic of the top three most worrying variants at the moment, i.e the English, South African, and Amazonian ones, and that occur at the molecular interface between SARS-CoV-2 spike protein and its human ACE2 receptor. We characterize these variants' effect in terms of (i) residue mobility, (ii) compactness, studying the network of interactions at the interface, and (iii) variation of shape complementarity via expanding the molecular surfaces in the Zernike basis. Overall, our analyses highlighted greater stability of the three variant complexes with respect to both the wild type and two negative control systems, especially for the English and Amazonian variants. In addition, in the three variants, we investigate the effects a not-yet observed mutation in position 501 could provoke on complex stability. We found that a phenylalanine mutation behaves similarly to the English variant and may cooperate in further increasing the stability of the South African one, hinting at the need for careful surveillance for the emergence of these mutations in the population. Ultimately, we show that the proposed observables describe key features for the stability of the ACE2-spike complex and can help to monitor further possible spike variants.

Indexed as

Amino Acid SubstitutionMutationAngiotensin-Converting Enzyme 2Molecular Dynamics SimulationProtein BindingSARS-CoV-2Angiotensin-Converting Enzyme 2

Identifiers

PMID34992214
PMCPMC8738749
OpenAlexW4225598922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.